Did you know @kiranshaw was India's first woman brewmaster?
She takes us back to the chapter that earned her the title of "Brewmaster"—and the journey that followed.
🎙️ Catch the full conversation on 'Baatein Dil Se with @NavikaKumar': https://t.co/1v75TpIEoS
What’s the secret to #superiorperformance at work or science ? I would just add “meaningfully different” to this definition. Tagging people who I think took the road less travelled @KiranManral@Anjaligulati13
'Innovation Is About Disrupting The Status Quo'
Biocon Founder Kiran Mazumdar-Shaw tells Shereen Bhan that technology has unlocked deeper insights into biology, but says breakthrough innovation still needs far greater capital than is currently available.
@HSBC | @Cognizant | @ficci_india | @IMFALtd
#WomenLeaders #FFF4 #TheWomensCollective #CNBCTV18Digital #Bengaluru #WomenInBusiness #WomenEntrepreneurs #LeadershipMatters #ChangeMakers #WomenWhoLead #InvestInWomen
'50% Of Biocon's Research Employees Are Women'
@kiranshaw calls for more gender parity in the workforce. Tells @ShereenBhan, there are many female entrepreneurs in India and this needs to be celebrated.
@HSBC_IN | @Cognizant | @ficci_india | @IMFALtd#WomenLeaders#FFF4 #TheWomensCollective #CNBCTV18Digital #Bengaluru #WomenInBusiness #WomenEntrepreneurs #LeadershipMatters #ChangeMakers #WomenWhoLead #InvestInWomen #CNBCTV18Digital
We at @Bioconlimited are incredibly proud to be part of the remarkable second cancer series by @BBCStoryWorks, and we truly value this partnership in supporting patients through their journey of diagnosis, treatment, recovery, and healing.
The beautifully made film captures the realities and resilience of those facing one of the world's toughest health challenges, and I hope viewers connect deeply with the stories it brings to life.
A salute to every patient fighting cancer with extraordinary courage, resilience, and patience. Your strength inspires us all, and your victories are a true celebration of life. #RewritingCancer
https://t.co/sb0FneyAnz
Let’s enable leadership in AI quantum & other emerging technologies through less regulation & greater investment from VCs & Capital markets.
Union Minister for Finance & Corporate Affairs Smt. @nsitharaman held discussions with a delegation led by @USTradeRep Mr. Jamieson Greer, in New Delhi, today.
Both sides exchanged views on strengthening bilateral trade and economic cooperation, with a focus on new opportunities for growth and deeper commercial engagement.
Communication chops in champ style @deepalinaair
Biocon's Strategic Shift: Changing the Narrative from Reverse Merger to Integration, ETBrandEquity https://t.co/eWUBr7PjZX
Need a contact at following companies. Kindly DM if you can connect me 1. Alpha alternatives
2. irage capital
3. Da vinci derivatives
4. Thincredblue securities
5. Samsarra algotech
6. Dolat capital
Honorary Consuls of Bengaluru had a very productive meeting with @CMofKarnataka Shri DK Shivakumar. Bengaluru & Karnataka are blessed with tech talent CM assured his commitment to improving infrastructure and ease of doing business.
@airtelindia hi need help. We paid up for new fibre connection on May 15th in Mumbai. Scheduled installation was 15th and 2 pm was fixed. Now no response from
Engineer assigned. This is rather urgent. @nairrr
It was a privilege to unveil “Bengaluru’s Soul”, designed by the acclaimed artist Jaume Plensa.
Bengaluru is a city that absorbs the world and still remains deeply itself. It is a city where science, culture and art coexist, where ambition and sensitivity meet.
This is a city built by many hands, many languages, many journeys and many dreams. People have come here from every part of Karnataka, from every part of India, and from across the world.
They have come to learn, to build, to create, to work and to belong.
And that is what gives Bengaluru its soul.
@kiranshaw@HariMarar@EmbEspIndia@blrairport_kn
Wonderful to host @kiranshaw at the Embassy today. We discussed the recent investments @Bioconlimited has made in the United States, Biocon’s participation at the 2026 #SelectUSASummit, and how our biopharma companies are partnering to create jobs and drive innovation.
Increasing incidences of obesity and high blood sugar triggering liver diseases which is likely to affect 1.8 bn people by 2050, finds a study.
https://t.co/EtmCKtR6JL
मराठी माणूस बुद्धिवान आणि कर्तबगार असूनही कार्पोरेट क्षेत्रातील उच्चपदस्थांमध्ये मराठी माणसांची संख्या खूपच कमी आहे. अशा वेळी भारतातील सर्वात मोठ्या बायोफार्मासिटिकल कंपनी असलेल्या ‘बायोकॉन’च्या मुख्य अधिकारी पदी झालेली श्रीहास तांबे यांची नियुक्ती मनाला सुखावणारी आहे. त्यांच्याकडे व्यवस्थापकिय संचालकाचा कार्यभारही देण्यात आलेला आहे. त्यांच्यासोबतच केदार उपाध्ये यांची सीएफओ म्हणून नियुक्ती करण्यात आलेली आहे. या दोन्ही मराठी अधिकाऱ्यांच्या नियुक्तीचा मराठी माणसाला अभिमान असून त्यांचे मनापासून अभिनंदन.
Biocon Founder Kiran Mazumdar-Shaw congratulates MeitY on the India AI Impact Summit and shares biotech wisdom. Life's adaptive energy-efficient systems like immune memory and cellular precision can elevate AI in drug discovery genomics precision medicine and AI-powered CRISPR for gene editing and smarter drugs.
For India, this is a path to biotech sovereignty with AI rooted in science trust and governance. Ms. Kiran will be sharing more at the #IndiaAIImpactSummit2026 in Delhi next week.
#ResponsibleAI #PeoplePlanetProgress
@PMOIndia@AshwiniVaishnaw@jitinprasada@PIB_India@SecretaryMEITY@abhish18@kavitabha@GoI_MeitY@_DigitalIndia@mygovindia@kiranshaw
“Biocon Biologics reported a robust Q3FY26 performance, with EBITDA of INR 700 crore, up over 44% year on year, driven by strong demand and favorable pricing across key markets. North America continued to power growth during the quarter.
We expanded our commercial portfolio with launches of Yesintek (bUstekinumab), Kirsty (bAspart), Jobevne (bBevacizumab), and Yesafili (bAflibercept), and are preparing for the launch of Vevzuo and Bosaya, our two bDenosumab products, in several markets globally. Inclusion of bTrastuzumab SubQ, bNivolumab and bPembrolizumab, in addition to bPertuzumab, will further strengthen our leadership in oncology and positions us well for sustained growth.”
- Shreehas Tambe, CEO & Managing Director, Biocon Biologics Limited
Read more: https://t.co/AMKj652HH2
#Q3FY26 #Biocon